Search
01/01/2022
Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism
Puig-Jove, C, Castelblanco, E, Falguera, M, Hernandez, M, Soldevila, B, Julian, MT, Teis, A, Julve, J, Barranco-Altirriba, M, Franch-Nadal, J, Puig-Domingo, M, Ortega, E, Amigo, N, Alonso, N, Mauricio, D. Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(1)DOI:10.1016/j.recesp.2021.02.013. PMID:33785266. IF:5.900(Q1/3D).
01/01/2022
Perfil lipoproteico por espectroscopia nuclear magnética en pacientes con insuficiencia cardiaca crónica comparado con controles emparejados
Teis A., Castelblanco E., Cediel G., Amigó N., Julve J., Ribalta J., Guardiola M., Franch J., Bermúdez-López M., Codina P., Lupón J., Mauricio D., Alonso N., Bayés-Genís A.. Perfil lipoproteico por espectroscopia nuclear magnética en pacientes con insuficiencia cardiaca crónica comparado con controles emparejados. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11)DOI:10.1016/j.recesp.2021.09.007. PMID:. IF:(Q/D).
01/01/2022
Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality
Ramon, J, Llaurado, G, Guerri, R, Climent, E, Ballesta, S, Benaiges, D, Lopez-Montesinos, I, Navarro, H, Fernandez, N, Carrera, MJ, Mauricio, D, Flores-Le Roux, JA, Chillaron, JJ. Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality. DIABETES CARE. 2022; 45(1)DOI:10.2337/dc21-1321. PMID:34782352. IF:16.200(Q1/1D).
01/01/2022
Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world
Franch-Nadal J., Granado-Casas M., Mata-Cases M., Ortega E., Vlacho B., Mauricio D.. Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world. Primary Care Diabetes. 2022; 16(6)DOI:10.1016/j.pcd.2022.10.005. PMID:36336605. IF:2.900(Q2/5D).